The race to deliver in 10 to 15 minutes is usually told as a logistics story: more dark stores, faster riders, tighter routes. But the real competition happens before an order is placed, inside the systems that decide what gets stocked, where it sits and when it will be needed. Quick commerce is becoming a business of prediction, and nowhere is that truer than in medicines.
Medicine is different from groceries in ways that no algorithm can wish away. India’s pharma supply chain spans thousands of manufacturers and distributors and a vast network of independent chemists.
On top of that sit requirements no grocery order faces: Schedule H and H1 drugs need a valid prescription and pharmacist oversight, every strip carries a batch and expiry date that demands first-expiry-first-out handling and fast traceability, and products like insulin and vaccines need cold-chain storage. Demand is also intensely local, shifting with seasonal infections and the refill cycles of chronic patients.
This is where AI and data intelligence earn their place. Models that combine sales history, seasonality, weather and local disease trends can forecast demand for a molecule at pin-code level, so each dark store is stocked for its own neighbourhood rather than a generic template. Patients managing diabetes, hypertension or thyroid conditions follow predictable refill cycles, and anticipating them improves both adherence and availability.
Expiry-aware systems can flag near-dated batches and suggest inter-store transfers, cutting write-offs while protecting patients. AI-assisted prescription reading can digitise orders and flag interactions or unclear entries, though the pharmacist must remain the decision-maker; the technology shortens the queue, it does not replace the check. For D2C and FMCG wellness brands, real-time stock, pricing and competitor tracking supports faster replenishment decisions, and AI copilots can surface patterns, such as a rising stock-out rate on one SKU in one city, that dashboards might bury.
Delivering this value depends on owning the foundation. Companies that build their own software control data quality and speed far better than those stitching together generic tools. Still, an algorithm is only as good as the information it receives. Manually updated inventory, inconsistent product master data and disconnected systems all undermine prediction, producing the failure customers feel most: a medicine shown as available but missing from the shelf, while another locality runs dry. In healthcare, that can mean a delayed dose. The foundation is unglamorous: clean master data, real-time stock updates and systems that talk to each other. Forecasting sophistication comes second.
That is why medicine fulfilment cannot be optimised for minutes alone. Prescription validation, pharmacist oversight, correct storage and regulatory compliance must be designed in as features, not treated as friction. Technology in this sector has to deliver speed, accuracy and accountability together.
The next phase of quick commerce in healthcare will not be won by whoever shaves off another two minutes. It will be won by whoever builds the most dependable system behind those minutes, connecting forecasting, inventory visibility and pharmacist-led compliance into one reliable flow. Speed is the promise customers see. The intelligence of the supply chain is what makes that promise safe to keep.